Lymphedema Clinical Trials 2024

Lymphedema Clinical Trials 2024

Lymphedema research studies recruiting patients in 2024 need your help. Receive premium care & cutting edge treatments by enrolling in lymphedema clinical trials today.

Trials for Truncal Lymphedema Patients

Trials for Breast Cancer Patients

Trials With No Placebo

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.

Introduction to lymphedema

What are the top hospitals conducting lymphedema research?

Lymphedema, a condition characterized by swelling in the arms or legs due to lymphatic system dysfunction, is being actively addressed by top hospitals across the United States and Canada. M D Anderson Cancer Center in Houston leads the way with three ongoing lymphedema trials and an overall record of four completed trials. This renowned institution embarked on its first lymphedema trial in 2012, demonstrating their commitment to finding effective treatments for this debilitating condition. In Nashville, Vanderbilt University Medical Center has made significant contributions as well, currently conducting two active trials for lymphedema and having completed five previous studies since initiating their inaugural trial in 2015.

Further north at Edmonton's Cross Cancer Institute, researchers are vigorously exploring new avenues to combat lymphedema through two active clinical trials while holding a solid track record of five historical investigations dating back to 2003- when they first began focusing specifically on this condition. Meanwhile,Olive View-University of California Los Angeles Medical Center situated at Sylmar has joined forces with dedication towards tackling current challenges; it is hosting two progressive experiments dealing with Lymphoedemas.Their journey started relatively recently compared to others around ten years ago from now (in 2012). Lastly but not least important Stanford University based out of Stanford has also dedicated itself towards addressing Lymphoedeams ; displaying efforts through concurrent participation withintwo promising investigational ventures; theirs can be traced back till2009

With these prestigious institutions paving the way forward, there is hope on the horizon for those living with lymphedema. Each trial conducted brings us closer to understanding this complex condition better and developing innovative approaches that could alleviate symptoms and enhance patients' quality of life. By working together across different locations, these top hospitals exemplify how collaborative research efforts have the potential to make lasting impacts on healthcare worldwide

Which are the best cities for lymphedema clinical trials?

When it comes to lymphedema clinical trials, several cities are at the forefront of research and development. Columbus, Ohio leads with 8 active trials focusing on quality-of-life assessment and imaging techniques. Houston, Texas follows closely behind with 6 ongoing studies exploring annual lymphedema screening and vascularized lymph node transfer. Additionally, Newark, Delaware; Des Moines, Iowa; and Wichita, Kansas each have 6 or 5 active trials examining various aspects of quality-of-life assessment. These cities offer individuals affected by lymphedema opportunities to participate in cutting-edge clinical trials that advance our understanding and treatment options for this condition.

Which are the top treatments for lymphedema being explored in clinical trials?

Clinical trials are paving the way for advancements in lymphedema treatment, with several top contenders currently under exploration. Quality-of-Life Assessment takes the lead with its focus on improving patients' well-being and is currently being tested in two active clinical trials. Another promising option is the Advanced Pneumatic Compression Device (APCD), which aims to provide effective relief through compression therapy and is undergoing evaluation in one ongoing trial. Additionally, researchers are investigating an ultrasound procedure as a potential treatment option for lymphedema, with one active trial exploring its efficacy. These innovative approaches hold promise for improving the management of lymphedema and enhancing patients' quality of life.

What are the most recent clinical trials for lymphedema?

Exciting advancements are being made in the field of lymphedema treatment, with several recent clinical trials showcasing promising outcomes. One such trial focuses on advanced pneumatic compression for lymphedema, aiming to enhance patient management and alleviate symptoms associated with this condition. Additionally, a study explored the use of microbubble contrast agent Lumason as a potential therapeutic approach for lymphedema patients. Another trial investigated the efficacy of acebilustat in managing lymphedema symptoms at Phase 2 level. Furthermore, two Phase 3 trials assessed prophylactic lymphaticonvenous anastomosis and locoregional radiation treatment-hypofractionation as potential strategies to combat lymphedema's impact on patients' lives. These groundbreaking studies offer hope for improved treatments and better quality of life for individuals affected by lymphedema.

What lymphedema clinical trials were recently completed?

Recently completed clinical trials have made significant strides in the field of lymphedema treatment. Notably, a trial exploring the efficacy of Uproleselan, conducted by Washington University School of Medicine, concluded successfully. Additionally, a trial sponsored by the National Cancer Institute (NCI) investigated the potential benefits of mRNA-1273 therapy and reached completion. These efforts highlight ongoing advancements in addressing lymphedema and offer hope for patients seeking improved therapies for this condition.